Skip to main content
. Author manuscript; available in PMC: 2023 Dec 1.
Published in final edited form as: ASAIO J. 2022 Nov 28;68(12):1475–1482. doi: 10.1097/MAT.0000000000001691

Table 4.

Echocardiogram measurements

Variable Na ≤ 134 mEq/L (n = 40) Na ≥ 135 mEq/L (n = 218) p-value

LV end-diastolic diameter (cm) 5.8 ± 1.2 5.9 ± 1.3 0.90
LV end-diastolic diameter index (cm/m2) 2.9 ± 0.6 2.9 ± 0.6 0.90
RV dilated (Y/N) 28 (70%) 137 (63%) 0.67
RV dilatation severity 0.89
 Mild 7 (25%) 41 (30%)
 Mild-moderate 0 (0%) 3 (2%)
 Moderate 11 (39%) 42 (31%)
 Moderate-severe 1 (4%) 3 (2%)
 Severe 4 (14%) 18 (13%)
 Indeterminate 5 (18%) 30 (22%)
RV systolic function reduced (Y/N) 32 (80%) 162 (74%) 0.70
RV dysfunction severity 0.77
 Mild 8 (25%) 53 (33%)
 Mild-moderate 1 (3%) 1 (1%)
 Moderate 12 (38%) 50 (31%)
 Moderate-severe 2 (6%) 10 (6%)
 Severe 6 (19%) 32 (20%)
 Indeterminate 3 (9%) 16 (10%)
LA volume (mL) 79.6 ± 38.3 84.0 ± 37.4 0.57
LA volume index (mL/m2) 39.7 ± 16.4 42.2 ± 18.2 0.50
RA dilated (Y/N) 17 (43%) 90 (41%) 0.41
Mitral regurgitation (at least moderate) 3 (8%) 20 (9%) 0.90
Aortic regurgitation (at least moderate) 1 (3%) 4 (2%) 0.52
Tricuspid regurgitation (at least moderate) 5 (13%) 19 (9%) 0.84
Tricuspid regurgitant peak velocity (m/s) 2.2 ± 0.8 2.2 ± 0.8 0.97

Transthoracic echocardiogram measurements when available at 3 months after implant in LVAD patients with and without hyponatremia. There are no significant differences between groups. LA, left atrium; LV, left ventricular; RV, right ventricle; RA, right atrium.